Nonsynonymous mutations in three anticoagulant genes in Japanese patients with adverse pregnancy outcomes

Sibai, 1999, Thrombophilias and adverse outcomes of pregnancy–what should a clinician do?, N Engl J Med, 340, 50, 10.1056/NEJM199901073400110 Bennett, 2012, Pregnancy loss and thrombophilia: the elusive link, Br J Haematol, 157, 529, 10.1111/j.1365-2141.2012.09112.x Blumenfeld, 1999, Thrombophilia-associated pregnancy wastage, Fertil Steril, 72, 765, 10.1016/S0015-0282(99)00360-X 2010, Practice bulletin no. 113: inherited thrombophilias in pregnancy, Obstet Gynecol, 116, 212, 10.1097/AOG.0b013e3181e8b050 Greer, 1999, Thrombosis in pregnancy: maternal and fetal issues, Lancet, 353, 1258, 10.1016/S0140-6736(98)10265-9 Pabinger, 2005, Thrombophilia and pregnancy outcomes, J Thromb Haemost, 3, 1603, 10.1111/j.1538-7836.2005.01417.x Rees, 1995, World distribution of factor V Leiden, Lancet, 346, 1133, 10.1016/S0140-6736(95)91803-5 Fujimura, 1995, Coagulation factor V Leiden mutation may have a racial background, Thromb Haemost, 74, 1381, 10.1055/s-0038-1649946 Miyata, 1998, The prothrombin gene G20210A mutation is not found among Japanese patients with deep vein thrombosis and healthy individuals, Blood Coagul Fibrinolysis, 9, 451, 10.1097/00001721-199807000-00011 Kinoshita, 2005, Protein S and protein C gene mutations in Japanese deep vein thrombosis patients, Clin Biochem, 38, 908, 10.1016/j.clinbiochem.2005.05.006 Kimura, 2006, Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients, Blood, 107, 1737, 10.1182/blood-2005-09-3892 Ikejiri, 2010, The association of protein S Tokushima-K196E with a risk of deep vein thrombosis, Int J Hematol, 92, 302, 10.1007/s12185-010-0671-0 Miyata, 2012, More on: racial differences in venous thromboembolism, J Thromb Haemost, 10, 319, 10.1111/j.1538-7836.2011.04578.x Yin, 2014, Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in Northeast Asians, J Thromb Thrombolysis, 37, 56, 10.1007/s11239-013-1005-x Miyata, 2006, Genetic risk factors for deep vein thrombosis among Japanese: importance of protein S K196E mutation, Int J Hematol, 83, 217, 10.1532/IJH97.A20514 Pecheniuk, 2008, Failure to validate association of gene polymorphisms in EPCR, PAR-1, FSAP and protein S Tokushima with venous thromboembolism among Californians of European ancestry, Thromb Haemost, 99, 453, 10.1160/TH07-10-0607 Liu, 2013, Protein S K196E mutation, a genetic risk factor for venous thromboembolism, is limited to Japanese, Thromb Res, 132, 314, 10.1016/j.thromres.2013.05.008 Kimura, 2006, Plasma protein S activity correlates with protein S genotype but is not sensitive to identify K196E mutant carriers, J Thromb Haemost, 4, 2010, 10.1111/j.1538-7836.2006.02071.x Preston, 1996, Increased fetal loss in women with heritable thrombophilia, Lancet, 348, 913, 10.1016/S0140-6736(96)04125-6 Kupferminc, 1999, Increased frequency of genetic thrombophilia in women with complications of pregnancy, N Engl J Med, 340, 9, 10.1056/NEJM199901073400102 Martinelli, 2000, Mutations in coagulation factors in women with unexplained late fetal loss, N Engl J Med, 343, 1015, 10.1056/NEJM200010053431405 Infante-Rivard, 2002, Absence of association of thrombophilia polymorphisms with intrauterine growth restriction, N Engl J Med, 347, 19, 10.1056/NEJM200207043470105 Rey, 2003, Thrombophilic disorders and fetal loss: a meta-analysis, Lancet, 361, 901, 10.1016/S0140-6736(03)12771-7 Kovalevsky, 2004, Evaluation of the association between hereditary thrombophilias and recurrent pregnancy loss: a meta-analysis, Arch Intern Med, 164, 558, 10.1001/archinte.164.5.558 Dudding, 2004, The association between adverse pregnancy outcomes and maternal factor V Leiden genotype: a meta-analysis, Thromb Haemost, 91, 700, 10.1160/TH03-10-0637 Franchi, 2004, Intrauterine growth restriction and genetic predisposition to thrombophilia, Haematologica, 89, 444 Verspyck, 2004, Thrombophilia and fetal growth restriction, Eur J Obstet Gynecol Reprod Biol, 113, 36, 10.1016/j.ejogrb.2003.06.007 Lissalde-Lavigne, 2005, Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case–control 'NOHA first' study, J Thromb Haemost, 3, 2178, 10.1111/j.1538-7836.2005.01581.x Dizon-Townson, 2005, The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus, Obstet Gynecol, 106, 517, 10.1097/01.AOG.0000173986.32528.ca Dudding, 2008, Factor V Leiden is associated with pre-eclampsia but not with fetal growth restriction: a genetic association study and meta-analysis, J Thromb Haemost, 6, 1869, 10.1111/j.1538-7836.2008.03134.x Kist, 2008, Thrombophilias and adverse pregnancy outcome - A confounded problem!, Thromb Haemost, 99, 77, 10.1160/TH07-05-0373 Scifres, 2008, The utility of thrombophilia testing in pregnant women with thrombosis: fact or fiction?, Am J Obstet Gynecol, 199, e1 Rodger, 2010, The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies, PLoS Med, 7, e1000292, 10.1371/journal.pmed.1000292 Silver, 2010, Prothrombin gene G20210A mutation and obstetric complications, Obstet Gynecol, 115, 14, 10.1097/AOG.0b013e3181c88918 Lykke, 2012, Thrombophilias and adverse pregnancy outcomes: Results from the Danish National Birth Cohort, J Thromb Haemost, 10, 1320, 10.1111/j.1538-7836.2012.04773.x Seligsohn, 2001, Genetic susceptibility to venous thrombosis, N Engl J Med, 344, 1222, 10.1056/NEJM200104193441607 Marik, 2008, Venous thromboembolic disease and pregnancy, N Engl J Med, 359, 2025, 10.1056/NEJMra0707993 Miyakis, 2006, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS), J Thromb Haemost, 4, 295, 10.1111/j.1538-7836.2006.01753.x Neki, 2011, Genetic analysis of patients with deep vein thrombosis during pregnancy and postpartum, Int J Hematol, 94, 150, 10.1007/s12185-011-0902-z Antonarakis, 1998, Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group, Hum Mutat, 11, 1, 10.1002/(SICI)1098-1004(1998)11:1<1::AID-HUMU1>3.0.CO;2-O Adzhubei, 2010, A method and server for predicting damaging missense mutations, Nat Methods, 7, 248, 10.1038/nmeth0410-248 Miyata, 2009, Prevalence of genetic mutations in protein S, protein C and antithrombin genes in Japanese patients with deep vein thrombosis, Thromb Res, 124, 14, 10.1016/j.thromres.2008.08.020